학술논문

Final analysis of phase II results with cemiplimab in metastatic basal cell carcinoma after hedgehog pathway inhibitors
Document Type
Article
Source
In Annals of Oncology February 2024 35(2):221-228
Subject
Onco-Immunology
Language
ISSN
0923-7534